{'fraction_non_alphanumeric': 0.021666666666666667, 'fraction_numerical': 0.0016666666666666668, 'mean_word_length': 5.3936170212765955, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Correction to "Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer's Disease".

■ ACKNOWLEDGMENTS We formally acknowledge the scientific contribution of our colleagues at Proteome Science plc and collaborators at the Institute of Psychiatry, King’s College London. We are grateful for grant funding from the Alzheimer’s Research U.K. and the NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at the South London and Maudsley NHS Foundation Trust and Kings College London. AddNeuroMed was funded through the EU FP6 program.